Les traitements antiviraux lors d`affection virale chez le chat

> STDI Pdf Couleur
PHARMACOLOGIE FÉLINE
Stéphane Bertagnoli
Inra, UMR 1225,
F-31076 Toulouse
Université de Toulouse
ENV de Toulouse
23, chemin des Capelles
F-31076 Toulouse
0,05 CFC
Références
par article lu
1. Arai M, Darman J, Lewis A,
Yamamoto JK. The use of
human hematopoietic growth
factors (rhGM-CSF and rhEPO)
as a supportive therapy for
FIV-infected cats. Vet. Immunol.
Immunopathol. 2000;
77(1-2):71-92.
2. Arai M, Earl DD, Yamamoto JK.
Is AZT/3TC therapy effective
against FIV infection or immunopathogenesis? Vet. Immunol.
Immunopathol. 2002;85(34):189-204.
3. Chabanne L. Adjuvants et
immunostimulants. Dans : Chabanne L. Immunologie clinique
du chien et du chat. Abrégés
vétérinaires. Éd. ElsevierMasson. 2006:321-329.
4. Collado VM, Gómez-Lucía E,
Tejerizo G et coll. Effect of type I
interferons on the expression
of feline leukaemia virus. Vet.
Microbiol. 2007;123(1-3):
180-186.
5. De Mari K, Maynard L,
Sanquer A, et coll. Therapeutic
effects of recombinant feline
interferon-omega on feline
leukemia virus (FeLV)-infected
and FeLV/feline immunodeficiency virus (FIV)-coinfected
symptomatic cats. J. Vet. Intern.
Med. 2004;18(4):477-482.
6. Drazenovich TL, Fascetti AJ,
Westermeyer HD et coll. Effects
of dietary lysine supplementation on upper respiratory and
ocular disease and detection
of infectious organisms in cats
within an animal shelter. Am. J.
Vet. Res. 2009;70(11):1391-1400.
7. Field HJ, Biswas S, Mohammad IT. Herpesvirus latency
and therapy--from a veterinary
perspective. Antiviral Res.
2006;71(2-3):127-133.
8. Fontenelle JP, Powell CC,
Veir JK et coll. Effect of topical
ophthalmic application of cidofovir on experimentally induced
primary ocular feline herpesvirus-1 infection in cats. Am. J. Vet.
Res. 2008;69(2):289-293.
9. Gaskell R, Dawson S, Radford A et coll. Feline herpesvirus.
Vet. Res. 2007;38(2):337-354.
PV10-CAN_Bertagnoli_online.indd 2
Les traitements
antiviraux lors d’affection
virale chez le chat
10. Gingerich DA. Lymphocyte
T-Cell immunomodulator (LTCI):
review of the immunopharmacology of a new veterinary
biologic. Intern. J. Appl. Res. Vet.
Med. 2008;6(2):61-68.
19. Maggs DJ, Clarke HE. In vitro
efficacy of ganciclovir, cidofovir,
penciclovir, foscarnet, idoxuridine, and acyclovir against
feline herpesvirus type-1. Am.
J. Vet. Res. 2004;65(4):400-403.
11. Gobert JM, Remington KM,
Zhu YQ, North TW. Multipledrug-resistant mutants of feline
immunodeficiency virus selected with 2’,3’-dideoxyinosine
alone and in combination with
3’-azido-3’-deoxythymidine.
Antimicrob. Agents Chemother.
1994;38(4):861-864.
20. Maggs DJ, Collins BK,
Thorne JG et coll. Effects of
L-lysine and L-arginine on
in vitro replication of feline
herpesvirus type-1. Am. J. Vet.
Res. 2000;61(12):1474-1478.
12. Haid C, Kaps S, Gönczi E
et coll. Pretreatment with
feline interferon omega and
the course of subsequent
infection with feline herpesvirus in cats. Vet. Ophthalmol.
2007;10(5):278-284.
13. Hartley C. Treatment of
corneal ulcers: What are the
medical options? J. Feline Med.
Surg. 2010;12(5):384-397.
14. Hartmann K. Antiviral and
immunodulatory chemotherapy. In: Greene CE (ed.). Infectious diseases of the dog and
cat. WB Saunders, Philadelphia.
2006:10-25.
15. Hartmann K, Block A,
Ferk G et coll. Treatment of
feline leukemia virus-infected
cats with paramunity inducer.
Vet. Immunol. Immunopathol.
1998;65(2-4):267-275.
16. Hartmann A, Donath B,
Beer HF et coll. Use of two
virustatica (AZT, PMEA) in the
treatment of FIV and of FeLV
seropositive cats with clinical
symptoms. Vet. Immunol.
Immunopathol. 1992;35
(1-2):167-175.
17. Hartmann K, Ritz S.
Treatment of cats with feline
infectious peritonitis. Vet.
Immunol. Immunopathol.
2008;123(1-2):172-175.
18. Hoover EA, Ebner JP,
Zeidner NS et coll. Early
therapy of feline leukemia virus
infection (FeLV-FAIDS) with
9-(2-phosphonylmethoxyethyl)
adenine (PMEA). Antiviral Res.
1991;16(1):77-92.
21. Maggs DJ, Nasisse MP,
Kass PH. Efficacy of oral supplementation with L-lysine in
cats latently infected with feline
herpesvirus. Am. J. Vet. Res.
2003;64(1):37-42.
22. Maggs DJ, Sykes JE,
Clarke HE et coll. Effects of
dietary lysine supplementation
in cats with enzootic upper respiratory disease. J. Feline Med.
Surg. 2007;9(2):97-108.
23. Malik R, Lessels NS, Webb S
et coll. Treatment of feline
herpesvirus-1 associated
disease in cats with famciclovir
and related drugs. J. Feline Med.
Surg. 2009;11(1):40-48.
24. McCaw DL, Boon GD,
Jergens AE, Kern MR, Bowles MH,
Johnson JC. Immunomodulation
therapy for feline leukemia virus
infection. J. Am. Anim. Hosp.
Assoc. 2001;37(4):356-363.
25. Mochizuki M, Nakatani H,
Yoshida M. Inhibitory effects of
recombinant feline interferon
on the replication of feline enteropathogenic viruses in vitro.
Vet. Microbiol. 1994;39(1-2):
145-152.
26. Pasquier J, Bertagnoli S,
Messud-Petit F et coll. Les antiviraux. In: Pasquier J, Bertagnoli S,
Messud-Petit F et coll. Virologie
humaine et animale. Éd. Dunod,
coll. Sciences Sup, cours, fiches
de synthèses et QCM, Paris.
2005:43-51.
27. Pedretti E, Passeri B,
Amadori M, et coll. Low-dose
interferon-α treatment for feline
immunodeficiency virus infection. Vet. Immunol. Immunopathol. 2006;109(3-4):245-254.
28. Radford AD, Coyne KP,
Dawson S et coll. Feline
calicivirus. Vet. Res. 2007;
38(2):319-335.
29. Rees TM, Lubinski JL.
Oral supplementation with
L-lysine did not prevent upper
respiratory infection in a shelter
population of cats. J. Feline
Med. Surg. 2008;10(5):510-513.
30. Riondato F, Gianella P,
Guglielmino R, Cagnasso A,
Bo S. Effects of interferon α
(IFN-α) therapy on peripheral
blood lymphocyte subsets
from FIV and FeLV naturally
infected cats. Vet. Res. Commun.
2003;27(Suppl. 1):429-432.
31. Ritz S, Egberink H,
Hartmann K. Effect of feline
interferon-omega on the
survival time and quality of life
of cats with feline infectious
peritonitis. J. Vet. Intern. Med.
2007;21(6):1193-1197.
32. Sandmeyer LS, Keller CB,
Bienzle D. Effects of interferon-α
on cytopathic changes and
titers for feline herpesvirus-1
in primary cultures of feline
corneal epithelial cells. Am. J.
Vet. Res. 2005;66(2):210-216.
33. Sato R, Inanami O, Tanaka Y,
Takase M, Naito Y. Oral administration of bovine lactoferrin
for treatment of intractable
stomatitis in feline immunodeficiency virus (FIV)-positive and
(FIV)-negative cats. Am. J. Vet.
Res. 1996;57(10):1443-1446.
34. Siebeck N, Hurley DJ, Garcia M et coll. Effects of human
recombinant α-2b interferon
and feline recombinant omega
interferon on in vitro replication
of feline herpesvirus-1. Am. J.
Vet. Res. 2006;67(8):1406-1411.
35. Siméon LA, Mercier P,
Mazière P et coll. Panleucopénie féline aiguë : à propos
d’un cas traité avec succès par
l’interféron ω. Pratique médicale
et chirurgicale de l’animal de
compagnie. 2009;44:125-131.
herpesvirus in cats. Am. J. Vet.
Res. 2002;63(3):99-103.
37. Thomasy SM, Maggs DJ,
Moulin NK et coll. Pharmacokinetics and safety of penciclovir
following oral administration of
famciclovir to cats. Am. J. Vet.
Res. 2007;68(11):1252-1258.
38. Van der Meer FJUM,
Schuurman NMP, Balzarini J
et coll. Comparative evaluation
of the activity of antivirals
towards feline immunodeficiency virus in different cell
culture systems. Antiviral Res.
2007;76(2):198-201.
39. Van der Meulen K, Garre B,
Croubels S et coll. In vitro
comparison of antiviral drugs
against feline herpesvirus 1.
BMC Vet. Res. 2006;2:13.
40. Weiss RC. Synergistic antiviral activities of acyclovir and
recombinant human leukocyte
(α) interferon on feline herpesvirus replication. Am. J. Vet. Res.
1989;50(10):1672-1677.
41. Weiss RC, Cox NR, OostromRam T. Effect of interferon or
Propionibacterium acnes on
the course of experimentally
induced feline infectious peritonitis in specific-pathogen-free
and random-source cats. Am.
J. Vet. Res. 1990;51(5):726-733.
42. Woo JC, Dean GA, Lavoy A,
Clark R, Moore PF. Investigation of recombinant human
insulin-like growth factor type
I in thymus regeneration in the
acute stage of experimental
FIV infection in juvenile cats.
AIDS Res. Hum. Retroviruses.
1999;15(15):1377-1388.
43. Zeidner NS, Myles MH,
Mathiason-DuBard CK et coll.
Α interferon (2b) in combination with zidovudine for the
treatment of presymptomatic
feline leukemia virus-induced
immunodeficiency syndrome.
Antimicrob. Agents Chemother.
1990;34(9):1749-1756.
36. Stiles J, Townsend WM,
Rogers QR et coll. Effect of oral
administration of L-lysine on
conjunctivitis caused by feline
19/11/10 14:42